Monte Rosa Therapeutics, Inc (GLUE) insider trading
Every open-market stock purchase and sale by Monte Rosa Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $3.5M over the last 12 months (26 sales). No open-market buys.
- Last insider buy: Chandra P. Leo (Insider), $58.4K, 18 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $3.5M (26 sales). Last close $16.37 on Jun 4, 2026.
Recent GLUE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 29, 2026 | Anthony M. Manning (Insider) | Sold | $231K |
| Jun 29, 2026 | Filip Janku (C-suite exec) | Sold | $138K |
| Jun 29, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | — |
| Jun 29, 2026 | Anthony M. Manning (Insider) | Bought (not open market) | — |
| Jun 24, 2026 | Filip Janku (C-suite exec) | Sold | $643K |
| Jun 24, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | — |
| Jun 23, 2026 | Filip Janku (C-suite exec) | Sold | $240K |
| Jun 23, 2026 | Sharon Townson (C-suite exec) | Sold | $60K |
| Jun 23, 2026 | Jennifer Champoux (COO) | Sold | $43.5K |
| Jun 23, 2026 | Jennifer Champoux (COO) | Bought (not open market) | — |
| Jun 23, 2026 | Filip Janku (C-suite exec) | Bought (not open market) | — |
| Jun 23, 2026 | Sharon Townson (C-suite exec) | Bought (not open market) | — |
| Jun 17, 2026 | Sharon Townson (C-suite exec) | Sold | $57K |
| Jun 17, 2026 | Jennifer Champoux (COO) | Sold | $41.3K |
| Jun 17, 2026 | Jennifer Champoux (COO) | Bought (not open market) | — |
| Jun 17, 2026 | Sharon Townson (C-suite exec) | Bought (not open market) | — |
| Jun 11, 2026 | Christine Siu (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Kimberly Blackwell (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Ali Behbahani (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Eric A Hughes (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Anthony M. Manning (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Jan Skvarka (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | Andrew N Schiff (Insider) | Bought (not open market) | — |
| Jun 1, 2026 | Markus Warmuth (CEO) | Sold | $97K |
| Jun 1, 2026 | Markus Warmuth (CEO) | Sold | $9.2K |
Who's trading GLUE
- Anthony M. Manning, Insider: sold $411K (2 sales), last Jun 29, 2026
- Filip Janku, C-suite exec: sold $1.2M (5 sales), last Jun 29, 2026
- Sharon Townson, C-suite exec: sold $284K (4 sales), last Jun 23, 2026
- Jennifer Champoux, COO: sold $210K (5 sales), last Jun 23, 2026
- Ali Behbahani, Insider: other filings, last Jun 11, 2026
- Kimberly Blackwell, Insider: other filings, last Jun 11, 2026
- Eric A Hughes, Insider: other filings, last Jun 11, 2026
- Andrew N Schiff, Insider: other filings, last Jun 11, 2026
- Christine Siu, Insider: other filings, last Jun 11, 2026
- Jan Skvarka, Insider: other filings, last Jun 11, 2026
- Markus Warmuth, CEO: sold $731K (9 sales), last Jun 1, 2026
- Philip Nickson, Officer: sold $151K (2 sales), last Apr 9, 2026
- Matthew Bowen, Insider: other filings, last Apr 6, 2026
- Edmund Dunn, Insider: sold $483K (4 sales), last Mar 4, 2026
Get free alerts when an insider at Monte Rosa Therapeutics, Inc files a new trade →